Trends of hospitalisations rates in a cohort of HIV-infected persons followed in an Italian hospital from 1998 to 2016
- PMID: 30869037
- PMCID: PMC6518563
- DOI: 10.1017/S0950268819000098
Trends of hospitalisations rates in a cohort of HIV-infected persons followed in an Italian hospital from 1998 to 2016
Abstract
Here we evaluated hospitalisation rates and associated risk factors of human immunodeficiency virus (HIV)-infected individuals who were followed up in an Italian reference hospital from 1998 to 2016. Incidence rates (IR) of hospitalisations were calculated for five study periods from 1998 to 2016. The random-effects Poisson regression model was used to assess risk factors for hospitalisation including demographic and clinical characteristics. To consider that more events may occur for the same subject, multiple failure-time data analysis was also performed for selected causes using the Cox proportional hazards model. We evaluated 2031 patients. During 13 173 person-years (py) of follow-up, 3356 hospital admissions were carried out for 756 patients (IR: 255 per 1000 py). IR decreased significantly over the study period, from 634 in 1998-2000 to 126 per 1000 py in 2013-2016. Major declines were detected for AIDS-defining events, non-HIV/AIDS-related infections and neurological diseases. Older age, female sex, longer HIV duration and HCV coinfection were associated with a higher hospitalisation risk, whereas higher CD4 nadir and antiretroviral therapy were associated with a reduced risk. Influence of advanced HIV disease markers declined over time. Hospitalisation rates decreased during the study period in most causes. The relative weight of hospitalisations for non-AIDS-related tumours, cardiovascular, respiratory and kidney diseases increased during the study period, whereas those for AIDS-defining events declined.
Keywords: Causes for hospitalisation; HIV; Poisson regression model; cohort study; hospitalisation rates; multiple failure-time data analysis.
Conflict of interest statement
I have read the journal's policy and the authors of this manuscript have the following competing interests: AB received non-financial support from Bristol-Myers Squibb and ViiV Healthcare, personal fees from Gilead Sciences. GB received travel grant from Bristol-Myers Squibb. RG received travel grant from Gilead, Mylan and Janssen-Cilag. ADL was a paid consultant or member of advisory boards for Gilead, ViiV Healthcare, AbbVie, Merck Sharp and Dohme, Roche, Bristol-Myers Squibb and Janssen-Cilag, and has received research grants and travel sponsorship from ViiV Healthcare and Merck Sharp & Dohme. SDG was a paid consultant or member of advisory boards for Gilead, ViiV Healthcare, Janssen-Cilag, Merck Sharp & Dohme and Bristol-Myers Squibb. The remaining authors have no funding or conflicts of interest to disclose.
Similar articles
-
Causes of hospitalisation among a cohort of people with HIV from a London centre followed from 2011 to 2018.BMC Infect Dis. 2021 Apr 29;21(1):395. doi: 10.1186/s12879-021-06082-y. BMC Infect Dis. 2021. PMID: 33926373 Free PMC article.
-
Hospitalizations of HIV patients in a major Israeli HIV/AIDS center during the years 2000 to 2012.Medicine (Baltimore). 2017 May;96(18):e6812. doi: 10.1097/MD.0000000000006812. Medicine (Baltimore). 2017. PMID: 28471983 Free PMC article.
-
Incidence of AIDS-defining cancers and virus-related and non-virus-related non-AIDS-defining cancers among HIV-infected patients compared with the general population in a large health district of Northern Italy, 1999-2009.HIV Med. 2013 Sep;14(8):481-90. doi: 10.1111/hiv.12034. Epub 2013 Apr 7. HIV Med. 2013. PMID: 23560682
-
Hospitalisation rates and associated factors in community-based cohorts of HIV-infected and -uninfected gay and bisexual men.HIV Med. 2016 May;17(5):327-39. doi: 10.1111/hiv.12312. Epub 2015 Sep 6. HIV Med. 2016. PMID: 26344061 Free PMC article.
-
Mortality and morbidity in patients with osteogenesis imperfecta in Denmark.Dan Med J. 2018 Apr;65(4):B5454. Dan Med J. 2018. PMID: 29619932 Review.
Cited by
-
Causes of hospitalisation among a cohort of people with HIV from a London centre followed from 2011 to 2018.BMC Infect Dis. 2021 Apr 29;21(1):395. doi: 10.1186/s12879-021-06082-y. BMC Infect Dis. 2021. PMID: 33926373 Free PMC article.
-
The influence of hospitalization and HIV severity on gastrointestinal PCR panel evaluation of HIV-related acute diarrhea in New York City: a retrospective, cross-sectional study.Therap Adv Gastroenterol. 2022 Apr 28;15:17562848221092593. doi: 10.1177/17562848221092593. eCollection 2022. Therap Adv Gastroenterol. 2022. PMID: 35509422 Free PMC article.
-
The factors associated with natural disease progression from HIV to AIDS in the absence of ART, a propensity score matching analysis.Epidemiol Infect. 2020 Feb 24;148:e57. doi: 10.1017/S0950268820000540. Epidemiol Infect. 2020. PMID: 32089142 Free PMC article.
-
All-cause hospitalisation among people living with HIV according to gender, mode of HIV acquisition, ethnicity, and geographical origin in Europe and North America: findings from the ART-CC cohort collaboration.Lancet Public Health. 2023 Oct;8(10):e776-e787. doi: 10.1016/S2468-2667(23)00178-0. Lancet Public Health. 2023. PMID: 37777287 Free PMC article.
-
Factors associated with hospitalizations for co-occurring HIV and opioid-related diagnoses: Evidence from the national inpatient sample, 2009-2017.Prev Med Rep. 2023 May 9;34:102225. doi: 10.1016/j.pmedr.2023.102225. eCollection 2023 Aug. Prev Med Rep. 2023. PMID: 37214165 Free PMC article.
References
-
- Buchacz K et al. (2008) Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994–2005. AIDS (London, England) 22, 1345–1354. - PubMed
-
- Gebo KA, Diener-West M and Moore RD (2001) Hospitalization rates in an urban cohort after the introduction of highly active antiretroviral therapy. Journal of Acquired Immune Deficiency Syndromes 27, 143–152. - PubMed
-
- Palella FJ Jr et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. New England Journal of Medicine 338, 853–860. - PubMed
-
- Paul S et al. (2002) Impact of antiretroviral therapy on decreasing hospitalization rates of HIV-infected patients in 2001. AIDS Research Human Retroviruses 18, 501–506. - PubMed
-
- Volberding PA and Deeks SG (2010) Antiretroviral therapy and management of HIV infection. Lancet 376, 49–62. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials